Literature DB >> 15341218

The neuroprotective effects of Semax in conditions of MPTP-induced lesions of the brain dopaminergic system.

N G Levitskaya1, E A Sebentsova, L A Andreeva, L Yu Alfeeva, A A Kamenskii, N F Myasoedov.   

Abstract

This report describes studies cf the effects of the ACTH(4-10) analog Semax (MEHFPGP) on the behavior of white rats with lesions to the brain dopaminergic system induced by the neurotoxin MPTP. Neurotoxin was given as single i.p. doses of 25 mg/kg. Neurotoxin injections were shown to decrease movement activity and increase anxiety in the animals. Daily intranasal administration of Semax at a dose of 0.2 mg/kg decreased the severity of MPTP-induced behavioral disturbances. The protective activity of Semax in MPTP-induced lesions of the brain dopaminergic system may be associated with both its modulating effect on the dopaminergic system and the neurotrophic action of the peptide.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15341218     DOI: 10.1023/b:neab.0000018752.59465.28

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


  19 in total

Review 1.  New vistas for melanocortins. Finally, an explanation for their pleiotropic functions.

Authors:  F L Strand
Journal:  Ann N Y Acad Sci       Date:  1999       Impact factor: 5.691

2.  [Dependence of neuropeptide physiological effects on a route of administration].

Authors:  A A Kamenskiĭ; O G Voskresenskaia; V A Dubynin; N G Levitskaia
Journal:  Ross Fiziol Zh Im I M Sechenova       Date:  2001-11

3.  [Peptide factors in processes of proliferation, differentiation, and extended viability of mammalian nervous system cells].

Authors:  I A Grivennikov; O V Dolotov; Iu I Gol'dina
Journal:  Mol Biol (Mosk)       Date:  1999 Jan-Feb

Review 4.  Effects of the ACTH4-9 analog Org2766 on brain plasticity: modulation of excitatory neurotransmission?

Authors:  B M Spruijt
Journal:  Psychoneuroendocrinology       Date:  1992-08       Impact factor: 4.905

Review 5.  Neuropeptides in learning and memory processes.

Authors:  D de Wied
Journal:  Behav Brain Res       Date:  1997-02       Impact factor: 3.332

6.  Biochemical pathophysiology of Parkinson's disease.

Authors:  O Hornykiewicz; S J Kish
Journal:  Adv Neurol       Date:  1987

Review 7.  ACTH-related peptides: receptors and signal transduction systems involved in their neurotrophic and neuroprotective actions.

Authors:  E M Hol; W H Gispen; P R Bär
Journal:  Peptides       Date:  1995       Impact factor: 3.750

8.  [Effect of different doses of ACTH fragments on the bodies of white rats].

Authors:  A A Kamenskiĭ; L V Antonova; N G Levitskaia
Journal:  Fiziol Zh SSSR Im I M Sechenova       Date:  1980-10

9.  Rapid induction of neurotrophin mRNAs in rat glial cell cultures by Semax, an adrenocorticotropic hormone analog.

Authors:  M I Shadrina; O V Dolotov; I A Grivennikov; P A Slominsky; L A Andreeva; L S Inozemtseva; S A Limborska; N F Myasoedov
Journal:  Neurosci Lett       Date:  2001-08-03       Impact factor: 3.046

10.  Rapid neurotrophic actions of an ACTH/MSH(4-9) analogue after nigrostriatal 6-OHDA lesioning.

Authors:  F J Antonawich; E C Azmitia; F L Strand
Journal:  Peptides       Date:  1993 Nov-Dec       Impact factor: 3.750

View more
  3 in total

1.  Semax corrects brain dysfunction caused by prenatal introduction of valproic acid.

Authors:  A V Malyshev; E V Razumkina; V A Dubynin; N F Myasoedov
Journal:  Dokl Biol Sci       Date:  2013-07-03

2.  Formation of spatial memory in rats with ischemic lesions to the prefrontal cortex; effects of a synthetic analog of ACTH(4-7).

Authors:  D N Silachev; S I Shram; F M Shakova; G A Romanova; N F Myasoedov
Journal:  Neurosci Behav Physiol       Date:  2009-09-23

3.  The effect of Semax and its C-end peptide PGP on the morphology and proliferative activity of rat brain cells during experimental ischemia: a pilot study.

Authors:  Vasily V Stavchansky; Vadim V Yuzhakov; Alexandra Yu Botsina; Veronika I Skvortsova; Lyubov N Bondurko; Marina G Tsyganova; Svetlana A Limborska; Nikolay F Myasoedov; Lyudmila V Dergunova
Journal:  J Mol Neurosci       Date:  2010-07-09       Impact factor: 3.444

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.